What is Thermal scientific?
Thermal science is a branch of scientific inquiry which deals specifically with heat and energy, through thermodynamics and heat transfer.
What does Thermo Scientific sell?
Thermo Fisher Scientific is an American supplier of scientific instrumentation, reagents and consumables, and software services. Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006.
What products does Thermo Fisher Scientific make?
Most Popular Categories
- Microplates.
- PCR Equipment and Supplies.
- Molecular Biology Reagents and Kits.
- Chromatography Columns and Cartridges.
- Chromatography Supplies.
- Cell Culture Media.
- Microbiological Media and Media Additives.
- Antibiotics and Supplements.
Is Thermo Fisher Scientific a biotech company?
From translating scientific discoveries to breakthrough medicines, Thermo Fisher Scientific stays a step ahead of your needs so you can go a step beyond in every stage of your scientific journey.
Is Thermo Fisher Scientific a good stock to buy?
Out of 10 analysts, 5 (50%) are recommending TMO as a Strong Buy, 3 (30%) are recommending TMO as a Buy, 1 (10%) are recommending TMO as a Hold, 0 (0%) are recommending TMO as a Sell, and 1 (10%) are recommending TMO as a Strong Sell. What is TMO’s earnings growth forecast for 2022-2024?
What is Thermofisher known for?
We offer services and products that help customers around the globe in laboratories and clinics, on production lines and out in the field. We’re a driving force in the research, healthcare, industrial and applied markets, generating approximately $40 billion in annual revenue.
What is Thermo Fisher famous for?
As the world’s leader in serving science, at Thermo Fisher Scientific, our professionals develop critical solutions—and build rewarding careers. We offer services and products that help customers around the globe in laboratories and clinics, on production lines and out in the field.
Why is Thermo Fisher stock falling?
Thermo Fisher Q4 Earnings Beat Estimates, Margins Down GAAP earnings per share was $4.17, reflecting a 33.2% drop on a year-over-year basis. The significant contribution from COVID-19 response revenues as well as acceleration in the company’s base business drove the company’s bottom line in the fourth quarter.